mRNA Vaccine Shows Promise in Reducing Melanoma Recurrence

A new study indicates that an mRNA vaccine significantly reduces the risk of melanoma recurrence by nearly 50%. This development highlights the potential of mRNA technology in cancer treatment.

1 Jun, 12:00 — 1 Jun, 12:00

Post Share

Sources

Showing 1 of 4 sources

NPRHigh77d ago

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

By Allison Aubrey

Read full article →

Coverage Timeline

First report: NPR · 1 Jun, 12:00|Full coverage: 4 · 5h|Window: 5h

Left-leaningCenterRight-leaning

NPR1 Jun, 12:00First to report

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

2h later

el-mundo1 Jun, 13:56

Una vacuna de ARNm reduce casi un 50% el riesgo de recaída en melanoma

3h later

tagesschau1 Jun, 16:56

Studie: mRNA-Impfung senkt das Risiko für Hautkrebs-Rückfall

telex1 Jun, 17:16Latest update

PERSPECTA

PERSPECTA

mRNA Vaccine Shows Promise in Reducing Melanoma Recurrence

Sources

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

Coverage Timeline

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

Una vacuna de ARNm reduce casi un 50% el riesgo de recaída en melanoma

Studie: mRNA-Impfung senkt das Risiko für Hautkrebs-Rückfall

Közel 60 százalékkal csökkentette a melanóma áttétképződésének kockázatát egy kísérleti vakcina

Related Stories

Study Reveals Elderly More Vulnerable to Extreme Heat Than Previously Thought

Nollywood Actor Ogogo Hassan's Daughters Seek Help for Father's Stage 4 Cancer

Cancer Survivor Erin Races Against Time for Chance of Motherhood

West Nile Fever Spreads in North Macedonia and Serbia, Causing Deaths

PERSPECTA